The interleukin inhibitors market is expected to gain growth at a potential rate of 14.46% in the forecast period of 2028. The rise in awareness amongst the consumers and physicians regarding the benefits of these inhibitors is the factor responsible for the market growth. Interleukin inhibitors are the type of immunosuppressive agents, which helps to limit the activity of interleukins....